STAT [27 April, 2017]
“Lab experiment: Asking undergrad chemists to help make drugs for neglected diseases”
Devex [25 April, 2017]
“The Geneva Commitment on neglected tropical diseases: key takeaways”
SciDev.net [24 April, 2017]
“Tackle NTDs with innovation, but not just from science”
Reuters [21 April, 2017]
“Progress in fighting tropical diseases but funding and conflicts pose challenges”
Radio Okapi [20 April, 2017]
“RDC: des efforts sont nécessaires pour éliminer les maladies tropicales négligées” – “DRC: efforts needed to eliminate neglected tropical diseases”
Devex [20 April, 2017]
“Commitments made on neglected tropical diseases at WHO summit”
PLOS NTDs [20 April, 2017]
“Neglected tropical diseases: A DFID perspective”
Le Temps [19 April, 2017]
“Des progrès dans la lutte contre les maladies tropicales négligées” – “Progress in addressing neglected tropical diseases”
Le Monde [19 April, 2017]
“Mobilisation contre les maladies tropicales négligées” – “Mobilization against neglected tropical diseases”
PLOS Blog [19 April, 2017]
“Combatting neglected tropical diseases: much progress, but millions of neglected patients lack access to care”
Devex [18 April, 2017]
“Strides in progress on neglected tropical diseases as global partners meet”
SEMTSI 2017
X National Congress of Tropical Medicine and International Health
October 23-25, 2017
Bilbao, Spain
Representatives from DNDi and GARDP took part in the event.
ECTMIH 2017
October 16-20, 2017
Antwerp, Belgium
DNDi presented on sleeping sickness, visceral leishmaniasis, mycetoma, and onchocerciasis.
Financial Times [18 April, 2017]
“The long road to elimination of neglected tropical diseases”
Financial Times [18 April, 2017]
“More engagement on neglected tropical diseases needed from drugmakers”
Healio [12 April, 2017]
“GHIT Fund awards $23 million for malaria, NTDs research”
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
[Tokyo, Japan – March 30, 2017]
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Daiichi Sankyo Company, Limited (hereafter, “Daiichi Sankyo”), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (hereafter, “DNDi”) with regard to a new research program, the Hit-to-Lead Project, with the aim to develop drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.
International Workshop on Onchocerciasis-associated Epilepsy (OAE)
October 12-14, 2017
Antwerp, Belgium
Belén Pedrique, Medical Manager, DNDi, participated in the first international workshop on onchocerciasis-associated epilepsy (OAE).
IMTechCon 2017
October 4-6, 2017
Chandigarh, India
Graeme Bilbe, R&D Director, DNDi and Suman Rijal, Director of DNDi Regional Office India took part in the event.